A PHASE 3 STUDY OF THE EFFICACY AND SAFETY OF PEFICITINIB (ASP015K) IN PATIENTS WITH RHEUMATOID ARTHRITIS WHO HAD AN INADEQUATE RESPONSE TO METHOTREXATE

被引：0
|
作者：
Takeuchi, Tsutomu [1 ]
Tanaka, Yoshiya [2 ]
Tanaka, Sakae [3 ]
Kawakami, Atsushi [4 ]
Iwasaki, Manabu [5 ]
Rokuda, Mitsuhiro [6 ]
Izutsu, Hiroyuki [6 ]
Ushijima, Satoshi [6 ]
Kaneko, Yuichiro [6 ]
Shiomi, Teruaki [6 ]
Yamada, Emi [6 ]
机构：
[1] Keio Univ, Tokyo, Japan
[2] Univ Occupat & Environm Hlth, Kitakyushu, Fukuoka, Japan
[3] Univ Tokyo, Tokyo, Japan
[4] Nagasaki Univ, Nagasaki, Japan
[5] Yokohama City Univ, Yokohama, Kanagawa, Japan
[6] Astellas Pharma Inc, Tokyo, Japan
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2019年 / 78卷
关键词：
D O I：
10.1136/annrheumdis-2019-eular.1580
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
OP0026
引用
收藏
页码：81 / 82
页数：2
相关论文
共 50 条
  • [21] COADMINISTRATION OF ASP015K, A NOVEL JANUS KINASE INHIBITOR, WITH METHOTREXATE DEMONSTRATES TOLERABILITY AND LACK OF PHARMACOKINETIC INTERACTIONS IN PATIENTS WITH RHEUMATOID ARTHRITIS
    Zhu, T.
    Oda, K.
    Valluri, U.
    Moore, B.
    Cao, Y.
    Chindalore, V.
    Akinlade, B.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2013, 72 : 898 - 898
  • [22] PEFICITINIB (ASP015K) INHIBITS MONOCYTE CHEMOTACTIC ACTIVITY VIA PROINFLAMMATORY CYTOKINE PRODUCTION IN RHEUMATOID ARTHRITIS FIBROBLAST-LIKE SYNOVIOCYTES
    Ikari, Yuzo
    Isozaki, Takeo
    Kasama, Tsuyoshi
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2019, 78 : 273 - 273
  • [23] Patient- and physician-reported outcomes from two phase 3 randomized studies (RAJ3 and RAJ4) of peficitinib (ASP015K) in Asian patients with rheumatoid arthritis
    Yoshiya Tanaka
    Tsutomu Takeuchi
    Hiroyuki Izutsu
    Yuichiro Kaneko
    Daisuke Kato
    Musashi Fukuda
    Mitsuhiro Rokuda
    Neil M. Schultz
    [J]. Arthritis Research & Therapy, 23
  • [24] A PHASE 2B STUDY OF AN ORAL JAK INHIBITOR ASP015K MONOTHERAPY IN JAPANESE PATIENTS WITH MODERATE TO SEVERE RHEUMATOID ARTHRITIS
    Takeuchi, T.
    Tanaka, Y.
    Iwasaki, M.
    Ishikura, H.
    Saeki, S.
    Kaneko, Y.
    Garg, J.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2014, 73 : 117 - 117
  • [25] Patient- and physician-reported outcomes from two phase 3 randomized studies (RAJ3 and RAJ4) of peficitinib (ASP015K) in Asian patients with rheumatoid arthritis
    Tanaka, Yoshiya
    Takeuchi, Tsutomu
    Izutsu, Hiroyuki
    Kaneko, Yuichiro
    Kato, Daisuke
    Fukuda, Musashi
    Rokuda, Mitsuhiro
    Schultz, Neil M.
    [J]. ARTHRITIS RESEARCH & THERAPY, 2021, 23 (01)
  • [26] Efficacy and Safety of Certolizumab Pegol Plus Methotrexate in Japanese Rheumatoid Arthritis Patients with An Inadequate Response to Methotrexate
    Yamamoto, Kazuhiko
    Takeuchi, Tsutomu
    Yamanaka, Hisashi
    Ishiguro, Naoki
    Tanaka, Yoshiya
    Eguchi, Katsumi
    Watanabe, Akira
    Origasa, Hideki
    Shoji, Toshiharu
    Sakamaki, Yoshiharu
    Miyasaka, Nobuyuki
    Koike, Takao
    [J]. ARTHRITIS AND RHEUMATISM, 2011, 63 (10): : S474 - S475
  • [27] Baricitinib in patients with rheumatoid arthritis with inadequate response to methotrexate: results from a phase 3 study
    Li, Z.
    Hu, J.
    Bao, C.
    Li, X.
    Li, X.
    Xu, J.
    Spindler, A. J.
    Zhang, X.
    Xu, J.
    He, D.
    Li, Z.
    Wang, G.
    Yang, Y.
    Wu, H.
    Ji, F.
    Tao, H.
    Zhan, L.
    Bai, F.
    Rooney, T. P.
    Zerbini, C. A. F.
    [J]. CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2020, 38 (04) : 732 - 741
  • [28] Peficitinib, a JAK Inhibitor, in the Treatment of Moderate-to-Severe Rheumatoid Arthritis in Patients With an Inadequate Response to Methotrexate
    Kivitz, A. J.
    Gutierrez-Urena, S. R.
    Poiley, J.
    Genovese, M. C.
    Kristy, R.
    Shay, K.
    Wang, X.
    Garg, J. P.
    Zubrzycka-Sienkiewicz, A.
    [J]. ARTHRITIS & RHEUMATOLOGY, 2017, 69 (04) : 709 - 719
  • [29] Clinical efficacy and safety of etanercept plus methotrexate or etanercept alone in rheumatoid arthritis patients with inadequate response to methotrexate: The ADORE study
    Taggart, A. J.
    van Riel, P. L. C. M.
    Reynolds, A.
    Sany, J.
    Gaubitz, M.
    Phillips, C.
    Pedersen, R.
    Singh, A.
    MacPeek, D.
    [J]. RHEUMATOLOGY, 2006, 45 : I45 - I45
  • [30] Efficacy and safety of combination etanercept and methotrexate versus etanercept alone in patients with rheumatoid arthritis with an inadequate response to methotrexate: the ADORE study
    van Riel, P. L. C. M.
    Taggart, A. J.
    Sany, J.
    Gaubitz, M.
    Nab, H. W.
    Pedersen, R.
    Freundlich, B.
    MacPeek, D.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2006, 65 (11) : 1478 - 1483
12345